MicroRNA-141 and MicroRNA-146b-5p Inhibit the Prometastatic Mesenchymal Characteristics through the RNA-binding Protein AUF1 Targeting the Transcription Factor ZEB1 and the Protein Kinase AKT-Reference-Cited by-同舟云学术

MicroRNA-141 and MicroRNA-146b-5p Inhibit the Prometastatic Mesenchymal Characteristics through the RNA-binding Protein AUF1 Targeting the Transcription Factor ZEB1 and the Protein Kinase AKT

Published:2014-11 Issue:45 Volume:289 Page:31433-31447
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Al-Khalaf Huda H.,Aboussekhra Abdelilah

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference49 articles.

1. microRNAs and RNA-binding proteins: a complex network of interactions and reciprocal regulations in cancer;Ciafrè;RNA Biol,2013

2. HuR recruits let-7/RISC to repress c-Myc expression;Kim;Genes Dev,2009

3. Competitive regulation of nucleolin expression by HuR and miR-494;Tominaga;Mol. Cell Biol,2011

4. Structure and genomic organization of the human AUF1 gene: alternative pre-mRNA splicing generates four protein isoforms;Wagner;Genomics,1998

5. The UUAG-specific RNA binding protein, heterogeneous nuclear ribonucleoprotein D0: common modular structure and binding properties of the 2xRBD-Gly family;Kajita;J. Biol. Chem,1995

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of AUF1 alternative splicing by hnRNPA1 and SRSF2 modulate the sensitivity of ovarian cancer cells to cisplatin;2023-11-28

2. Unleashing the pathological imprinting of cancer in autoimmunity: Is ZEB1 the answer?;Life Sciences;2023-11

3. Interactions between circRNAs and miR-141 in Cancer: From Pathogenesis to Diagnosis and Therapy;International Journal of Molecular Sciences;2023-07-24

4. Functional Role of RBP in Osteosarcoma: Regulatory Mechanism and Clinical Therapy;Analytical Cellular Pathology;2023-06-30

5. Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma;Frontiers in Oncology;2023-06-19